Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Medical Imaging Techniques and Applications, and Advanced MRI Techniques and Applications.
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer’s Disease in a Clinical Setting
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Comparison of Early-Phase <sup>11</sup>C-Deuterium-l-Deprenyl and <sup>11</sup>C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease
Comparability of [ <sup>18</sup> F]THK5317 and [ <sup>11</sup> C]PIB blood flow proxy images with [ <sup>18</sup> F]FDG positron emission tomography in Alzheimer’s disease
Tracer Kinetic Analysis of (<i>S</i>)<i>-</i><sup>18</sup>F-THK5117 as a PET Tracer for Assessing Tau Pathology
Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
Mild cognitive impairment with suspected nonamyloid pathology (SNAP)
Prediction of AD dementia by biomarkers following the NIA‐AA and IWG diagnostic criteria in MCI patients from three European memory clinics
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Combination of <sup>18</sup> F-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by <sup>11</sup> C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining <sup>11</sup> C-Pittsburgh Compound B and <sup>18</sup> F-FDG
Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease